Search results
Pfizer says tweaked COVID-19 shots boost omicron protection
KRGV Rio Grande Valley· 5 days agoPfizer announced Saturday that tweaking its COVID-19 vaccine to better target the omicron variant is...
The new technology inside COVID-19 vaccines— mRNA
KRGV Rio Grande Valley· 2 days agoWhen you think of vaccines, you may think about traditional vaccines with weak or inactive parts of a virus to trigger an immune response. Today...
FDA approves Moderna's RSV vaccine, its second marketed product
USA TODAY via Yahoo News· 4 days agoIt will be sold under the brand name mRESVIA The company has said mRNA vaccines, which teach the body to make specific proteins that the immune system can recognize and...
Fauci’s testimony reverberates in Florida
Politico· 2 hours agoBut Fauci didn’t budge on the importance of vaccines and predicted 1 million more people would have died if the virus had been allowed to... comments come roughly six before ...
Pfizer says its its lung cancer drug Lorbrena could be a $1 billion blockbuster
Quartz· 4 days agoPharma giant Pfizer said that its lung cancer drug Lorbrena could reach blockbuster status by 2030...
COVID Shots Could Use Another Update, Study Suggests
MedPage Today· 6 days agoThe updated monovalent XBB.1.5 COVID-19 vaccines were effective against Omicron subvariants circulating during the most recent respiratory virus season,...
Current COVID boosters offer good protection against severe outcomes but less so against JN.1
Center for Infectious Disease Research and Policy· 5 days agoProtection against infection 4 weeks after vaccination was 52%, and against COVID-related hospital...
US approves Moderna’s RSV vaccine for older adults | Fox 11 Tri Cities Fox 41 Yakima
FOX 11/41 Yakima· 4 days agovaccine for older adults — marking the first time any mRNA shot has been authorized against a...
Moderna wins FDA approval for RSV vaccine
BioPharma Dive via Yahoo Finance· 4 days agoThe OK for mResvia adds another option for preventing RSV-related disease in older adults, one year after the agency cleared shots from GSK and Pfizer.
Guillain-Barre Syndrome Rates After RSV Shots in Sync With Trial Data, CDC Says
MedPage Today· 4 days agoReporting System (VAERS) revealed that there were 1.5 reports of GBS per 1 million doses administered of the GSK RSV vaccine (Arexvy), and 5 reports per 1 million doses administered ...
